nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2C8—Mometasone—systemic scleroderma	0.2	0.292	CbGbCtD
Primidone—CYP1A2—Pentoxifylline—systemic scleroderma	0.105	0.153	CbGbCtD
Primidone—CYP1A2—Leflunomide—systemic scleroderma	0.0998	0.146	CbGbCtD
Primidone—CYP2C9—Leflunomide—systemic scleroderma	0.0899	0.131	CbGbCtD
Primidone—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0796	0.116	CbGbCtD
Primidone—CYP2C19—Prednisone—systemic scleroderma	0.0534	0.0779	CbGbCtD
Primidone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0323	0.0471	CbGbCtD
Primidone—Muscle contracture—Captopril—systemic scleroderma	0.0271	0.086	CcSEcCtD
Primidone—CYP3A4—Prednisone—systemic scleroderma	0.0258	0.0377	CbGbCtD
Primidone—Anaemia megaloblastic—Azathioprine—systemic scleroderma	0.0155	0.0493	CcSEcCtD
Primidone—Personality change—Prednisone—systemic scleroderma	0.00918	0.0292	CcSEcCtD
Primidone—Anaemia megaloblastic—Methotrexate—systemic scleroderma	0.00624	0.0198	CcSEcCtD
Primidone—Apathy—Mycophenolic acid—systemic scleroderma	0.00461	0.0146	CcSEcCtD
Primidone—Flat affect—Mycophenolic acid—systemic scleroderma	0.00456	0.0145	CcSEcCtD
Primidone—Blood disorder—Leflunomide—systemic scleroderma	0.00413	0.0131	CcSEcCtD
Primidone—Blood disorder—Mycophenolic acid—systemic scleroderma	0.00394	0.0125	CcSEcCtD
Primidone—Nystagmus—Mycophenolate mofetil—systemic scleroderma	0.00364	0.0116	CcSEcCtD
Primidone—Apathy—Mycophenolate mofetil—systemic scleroderma	0.00364	0.0116	CcSEcCtD
Primidone—Flat affect—Mycophenolate mofetil—systemic scleroderma	0.0036	0.0114	CcSEcCtD
Primidone—Blood disorder—Mycophenolate mofetil—systemic scleroderma	0.00311	0.00988	CcSEcCtD
Primidone—Drowsiness—Pentoxifylline—systemic scleroderma	0.00309	0.00982	CcSEcCtD
Primidone—Ataxia—Captopril—systemic scleroderma	0.00286	0.00908	CcSEcCtD
Primidone—Suicidal ideation—Prednisone—systemic scleroderma	0.00251	0.00798	CcSEcCtD
Primidone—Eruption—Methotrexate—systemic scleroderma	0.00239	0.0076	CcSEcCtD
Primidone—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.00233	0.00741	CcSEcCtD
Primidone—Ataxia—Mycophenolic acid—systemic scleroderma	0.00225	0.00714	CcSEcCtD
Primidone—Anaemia—Pentoxifylline—systemic scleroderma	0.00223	0.00709	CcSEcCtD
Primidone—Agranulocytosis—Captopril—systemic scleroderma	0.00218	0.00694	CcSEcCtD
Primidone—Diplopia—Lisinopril—systemic scleroderma	0.00215	0.00684	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00204	0.00649	CcSEcCtD
Primidone—Ataxia—Lisinopril—systemic scleroderma	0.00202	0.00643	CcSEcCtD
Primidone—Visual disturbance—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00632	CcSEcCtD
Primidone—Skin disorder—Pentoxifylline—systemic scleroderma	0.00191	0.00608	CcSEcCtD
Primidone—Agranulocytosis—Azathioprine—systemic scleroderma	0.00191	0.00606	CcSEcCtD
Primidone—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00599	CcSEcCtD
Primidone—Anorexia—Pentoxifylline—systemic scleroderma	0.00188	0.00597	CcSEcCtD
Primidone—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00585	CcSEcCtD
Primidone—Agranulocytosis—Leflunomide—systemic scleroderma	0.0018	0.00572	CcSEcCtD
Primidone—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00179	0.0057	CcSEcCtD
Primidone—Arthralgia—Mometasone—systemic scleroderma	0.00177	0.00564	CcSEcCtD
Primidone—Somnolence—Pentoxifylline—systemic scleroderma	0.00175	0.00557	CcSEcCtD
Primidone—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00172	0.00546	CcSEcCtD
Primidone—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00171	0.00544	CcSEcCtD
Primidone—Connective tissue disorder—Leflunomide—systemic scleroderma	0.0017	0.00541	CcSEcCtD
Primidone—Anaemia—Captopril—systemic scleroderma	0.00169	0.00537	CcSEcCtD
Primidone—Depression—Lisinopril—systemic scleroderma	0.00165	0.00525	CcSEcCtD
Primidone—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.00162	0.00516	CcSEcCtD
Primidone—Anorexia—Mometasone—systemic scleroderma	0.00162	0.00515	CcSEcCtD
Primidone—Eye disorder—Leflunomide—systemic scleroderma	0.00162	0.00514	CcSEcCtD
Primidone—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00159	0.00506	CcSEcCtD
Primidone—Arthralgia—Captopril—systemic scleroderma	0.00156	0.00495	CcSEcCtD
Primidone—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00155	0.00492	CcSEcCtD
Primidone—Agranulocytosis—Lisinopril—systemic scleroderma	0.00155	0.00492	CcSEcCtD
Primidone—Eye disorder—Mycophenolic acid—systemic scleroderma	0.00154	0.00491	CcSEcCtD
Primidone—Mental disorder—Leflunomide—systemic scleroderma	0.00152	0.00482	CcSEcCtD
Primidone—Malnutrition—Leflunomide—systemic scleroderma	0.00151	0.00479	CcSEcCtD
Primidone—Decreased appetite—Mometasone—systemic scleroderma	0.00148	0.0047	CcSEcCtD
Primidone—Anaemia—Azathioprine—systemic scleroderma	0.00148	0.00469	CcSEcCtD
Primidone—Fatigue—Mometasone—systemic scleroderma	0.00147	0.00466	CcSEcCtD
Primidone—Depression—Mycophenolate mofetil—systemic scleroderma	0.00145	0.0046	CcSEcCtD
Primidone—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00145	0.0046	CcSEcCtD
Primidone—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00144	0.00457	CcSEcCtD
Primidone—Anorexia—Captopril—systemic scleroderma	0.00142	0.00452	CcSEcCtD
Primidone—Asthenia—Pentoxifylline—systemic scleroderma	0.00141	0.00449	CcSEcCtD
Primidone—Anaemia—Leflunomide—systemic scleroderma	0.00139	0.00443	CcSEcCtD
Primidone—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00136	0.00432	CcSEcCtD
Primidone—Arthralgia—Azathioprine—systemic scleroderma	0.00136	0.00432	CcSEcCtD
Primidone—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00431	CcSEcCtD
Primidone—Vertigo—Leflunomide—systemic scleroderma	0.00135	0.0043	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00135	0.00429	CcSEcCtD
Primidone—Anaemia—Mycophenolic acid—systemic scleroderma	0.00133	0.00422	CcSEcCtD
Primidone—Somnolence—Captopril—systemic scleroderma	0.00133	0.00422	CcSEcCtD
Primidone—Mental disorder—Lisinopril—systemic scleroderma	0.0013	0.00414	CcSEcCtD
Primidone—Dizziness—Pentoxifylline—systemic scleroderma	0.0013	0.00414	CcSEcCtD
Primidone—Decreased appetite—Captopril—systemic scleroderma	0.0013	0.00412	CcSEcCtD
Primidone—Malnutrition—Lisinopril—systemic scleroderma	0.0013	0.00412	CcSEcCtD
Primidone—Vertigo—Mycophenolic acid—systemic scleroderma	0.00129	0.00411	CcSEcCtD
Primidone—Fatigue—Captopril—systemic scleroderma	0.00129	0.00409	CcSEcCtD
Primidone—Arthralgia—Leflunomide—systemic scleroderma	0.00128	0.00408	CcSEcCtD
Primidone—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00407	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00127	0.00405	CcSEcCtD
Primidone—Skin disorder—Azathioprine—systemic scleroderma	0.00127	0.00402	CcSEcCtD
Primidone—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00399	CcSEcCtD
Primidone—Vomiting—Pentoxifylline—systemic scleroderma	0.00125	0.00398	CcSEcCtD
Primidone—Psychotic disorder—Prednisone—systemic scleroderma	0.00125	0.00397	CcSEcCtD
Primidone—Rash—Pentoxifylline—systemic scleroderma	0.00124	0.00395	CcSEcCtD
Primidone—Dermatitis—Pentoxifylline—systemic scleroderma	0.00124	0.00394	CcSEcCtD
Primidone—Headache—Pentoxifylline—systemic scleroderma	0.00123	0.00392	CcSEcCtD
Primidone—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00122	0.00389	CcSEcCtD
Primidone—Asthenia—Mometasone—systemic scleroderma	0.00122	0.00388	CcSEcCtD
Primidone—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00387	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00122	0.00386	CcSEcCtD
Primidone—Nervous system disorder—Leflunomide—systemic scleroderma	0.00121	0.00384	CcSEcCtD
Primidone—Anaemia—Lisinopril—systemic scleroderma	0.0012	0.00381	CcSEcCtD
Primidone—Skin disorder—Leflunomide—systemic scleroderma	0.0012	0.0038	CcSEcCtD
Primidone—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00119	0.00377	CcSEcCtD
Primidone—Anorexia—Leflunomide—systemic scleroderma	0.00117	0.00373	CcSEcCtD
Primidone—Nausea—Pentoxifylline—systemic scleroderma	0.00117	0.00372	CcSEcCtD
Primidone—Vertigo—Lisinopril—systemic scleroderma	0.00116	0.0037	CcSEcCtD
Primidone—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00115	0.00366	CcSEcCtD
Primidone—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00363	CcSEcCtD
Primidone—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00114	0.00362	CcSEcCtD
Primidone—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00361	CcSEcCtD
Primidone—Visual disturbance—Methotrexate—systemic scleroderma	0.00113	0.00358	CcSEcCtD
Primidone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00112	0.00358	CcSEcCtD
Primidone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00112	0.00356	CcSEcCtD
Primidone—Anorexia—Mycophenolic acid—systemic scleroderma	0.00112	0.00356	CcSEcCtD
Primidone—Arthralgia—Lisinopril—systemic scleroderma	0.0011	0.00351	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.0011	0.00348	CcSEcCtD
Primidone—Vomiting—Mometasone—systemic scleroderma	0.00108	0.00343	CcSEcCtD
Primidone—Rash—Mometasone—systemic scleroderma	0.00107	0.00341	CcSEcCtD
Primidone—Asthenia—Captopril—systemic scleroderma	0.00107	0.0034	CcSEcCtD
Primidone—Dermatitis—Mometasone—systemic scleroderma	0.00107	0.0034	CcSEcCtD
Primidone—Decreased appetite—Leflunomide—systemic scleroderma	0.00107	0.0034	CcSEcCtD
Primidone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00107	0.0034	CcSEcCtD
Primidone—Headache—Mometasone—systemic scleroderma	0.00106	0.00338	CcSEcCtD
Primidone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00106	0.00338	CcSEcCtD
Primidone—Fatigue—Leflunomide—systemic scleroderma	0.00106	0.00337	CcSEcCtD
Primidone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00333	CcSEcCtD
Primidone—Somnolence—Mycophenolic acid—systemic scleroderma	0.00104	0.00332	CcSEcCtD
Primidone—Skin disorder—Lisinopril—systemic scleroderma	0.00103	0.00326	CcSEcCtD
Primidone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00102	0.00324	CcSEcCtD
Primidone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00324	CcSEcCtD
Primidone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00101	0.00322	CcSEcCtD
Primidone—Fatigue—Mycophenolic acid—systemic scleroderma	0.00101	0.00322	CcSEcCtD
Primidone—Nausea—Mometasone—systemic scleroderma	0.00101	0.00321	CcSEcCtD
Primidone—Anorexia—Lisinopril—systemic scleroderma	0.00101	0.0032	CcSEcCtD
Primidone—Ataxia—Methotrexate—systemic scleroderma	0.001	0.00319	CcSEcCtD
Primidone—Dizziness—Captopril—systemic scleroderma	0.000987	0.00314	CcSEcCtD
Primidone—Depression—Prednisone—systemic scleroderma	0.000982	0.00312	CcSEcCtD
Primidone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000966	0.00307	CcSEcCtD
Primidone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000963	0.00306	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00096	0.00305	CcSEcCtD
Primidone—Vomiting—Captopril—systemic scleroderma	0.000949	0.00302	CcSEcCtD
Primidone—Rash—Captopril—systemic scleroderma	0.000941	0.00299	CcSEcCtD
Primidone—Dermatitis—Captopril—systemic scleroderma	0.000941	0.00299	CcSEcCtD
Primidone—Somnolence—Lisinopril—systemic scleroderma	0.00094	0.00299	CcSEcCtD
Primidone—Headache—Captopril—systemic scleroderma	0.000935	0.00297	CcSEcCtD
Primidone—Decreased appetite—Lisinopril—systemic scleroderma	0.000919	0.00292	CcSEcCtD
Primidone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000913	0.0029	CcSEcCtD
Primidone—Fatigue—Lisinopril—systemic scleroderma	0.000912	0.0029	CcSEcCtD
Primidone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000909	0.00289	CcSEcCtD
Primidone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.0009	0.00286	CcSEcCtD
Primidone—Nausea—Captopril—systemic scleroderma	0.000887	0.00282	CcSEcCtD
Primidone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000883	0.00281	CcSEcCtD
Primidone—Asthenia—Leflunomide—systemic scleroderma	0.000883	0.00281	CcSEcCtD
Primidone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000869	0.00276	CcSEcCtD
Primidone—Dizziness—Azathioprine—systemic scleroderma	0.000862	0.00274	CcSEcCtD
Primidone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000844	0.00268	CcSEcCtD
Primidone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000842	0.00268	CcSEcCtD
Primidone—Vomiting—Azathioprine—systemic scleroderma	0.000828	0.00263	CcSEcCtD
Primidone—Eye disorder—Prednisone—systemic scleroderma	0.000826	0.00263	CcSEcCtD
Primidone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000824	0.00262	CcSEcCtD
Primidone—Drowsiness—Methotrexate—systemic scleroderma	0.000823	0.00262	CcSEcCtD
Primidone—Rash—Azathioprine—systemic scleroderma	0.000822	0.00261	CcSEcCtD
Primidone—Dermatitis—Azathioprine—systemic scleroderma	0.000821	0.00261	CcSEcCtD
Primidone—Depression—Methotrexate—systemic scleroderma	0.000821	0.00261	CcSEcCtD
Primidone—Headache—Azathioprine—systemic scleroderma	0.000816	0.00259	CcSEcCtD
Primidone—Dizziness—Leflunomide—systemic scleroderma	0.000814	0.00259	CcSEcCtD
Primidone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000805	0.00256	CcSEcCtD
Primidone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.0008	0.00254	CcSEcCtD
Primidone—Vomiting—Leflunomide—systemic scleroderma	0.000782	0.00249	CcSEcCtD
Primidone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000776	0.00247	CcSEcCtD
Primidone—Rash—Leflunomide—systemic scleroderma	0.000776	0.00247	CcSEcCtD
Primidone—Dermatitis—Leflunomide—systemic scleroderma	0.000775	0.00246	CcSEcCtD
Primidone—Mental disorder—Prednisone—systemic scleroderma	0.000774	0.00246	CcSEcCtD
Primidone—Nausea—Azathioprine—systemic scleroderma	0.000774	0.00246	CcSEcCtD
Primidone—Headache—Leflunomide—systemic scleroderma	0.000771	0.00245	CcSEcCtD
Primidone—Malnutrition—Prednisone—systemic scleroderma	0.000769	0.00245	CcSEcCtD
Primidone—Agranulocytosis—Methotrexate—systemic scleroderma	0.000768	0.00244	CcSEcCtD
Primidone—Asthenia—Lisinopril—systemic scleroderma	0.000759	0.00241	CcSEcCtD
Primidone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000746	0.00237	CcSEcCtD
Primidone—Rash—Mycophenolic acid—systemic scleroderma	0.00074	0.00235	CcSEcCtD
Primidone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000739	0.00235	CcSEcCtD
Primidone—Headache—Mycophenolic acid—systemic scleroderma	0.000735	0.00234	CcSEcCtD
Primidone—Nausea—Leflunomide—systemic scleroderma	0.000731	0.00232	CcSEcCtD
Primidone—Visual impairment—Methotrexate—systemic scleroderma	0.000712	0.00226	CcSEcCtD
Primidone—Anaemia—Prednisone—systemic scleroderma	0.000711	0.00226	CcSEcCtD
Primidone—Dizziness—Lisinopril—systemic scleroderma	0.000699	0.00222	CcSEcCtD
Primidone—Nausea—Mycophenolic acid—systemic scleroderma	0.000697	0.00222	CcSEcCtD
Primidone—Vertigo—Prednisone—systemic scleroderma	0.000691	0.0022	CcSEcCtD
Primidone—Eye disorder—Methotrexate—systemic scleroderma	0.00069	0.00219	CcSEcCtD
Primidone—Vomiting—Lisinopril—systemic scleroderma	0.000672	0.00214	CcSEcCtD
Primidone—Rash—Lisinopril—systemic scleroderma	0.000667	0.00212	CcSEcCtD
Primidone—Dermatitis—Lisinopril—systemic scleroderma	0.000666	0.00212	CcSEcCtD
Primidone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000665	0.00211	CcSEcCtD
Primidone—Headache—Lisinopril—systemic scleroderma	0.000662	0.00211	CcSEcCtD
Primidone—Arthralgia—Prednisone—systemic scleroderma	0.000655	0.00208	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000651	0.00207	CcSEcCtD
Primidone—Mental disorder—Methotrexate—systemic scleroderma	0.000647	0.00206	CcSEcCtD
Primidone—Malnutrition—Methotrexate—systemic scleroderma	0.000643	0.00204	CcSEcCtD
Primidone—Nausea—Lisinopril—systemic scleroderma	0.000628	0.002	CcSEcCtD
Primidone—Nervous system disorder—Prednisone—systemic scleroderma	0.000616	0.00196	CcSEcCtD
Primidone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000613	0.00195	CcSEcCtD
Primidone—Skin disorder—Prednisone—systemic scleroderma	0.00061	0.00194	CcSEcCtD
Primidone—Anorexia—Prednisone—systemic scleroderma	0.000599	0.0019	CcSEcCtD
Primidone—Anaemia—Methotrexate—systemic scleroderma	0.000594	0.00189	CcSEcCtD
Primidone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000589	0.00187	CcSEcCtD
Primidone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000584	0.00186	CcSEcCtD
Primidone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000584	0.00185	CcSEcCtD
Primidone—Headache—Mycophenolate mofetil—systemic scleroderma	0.00058	0.00184	CcSEcCtD
Primidone—Vertigo—Methotrexate—systemic scleroderma	0.000578	0.00184	CcSEcCtD
Primidone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000572	0.00182	CcSEcCtD
Primidone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00175	CcSEcCtD
Primidone—Arthralgia—Methotrexate—systemic scleroderma	0.000547	0.00174	CcSEcCtD
Primidone—Decreased appetite—Prednisone—systemic scleroderma	0.000546	0.00173	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000544	0.00173	CcSEcCtD
Primidone—Fatigue—Prednisone—systemic scleroderma	0.000541	0.00172	CcSEcCtD
Primidone—Nervous system disorder—Methotrexate—systemic scleroderma	0.000515	0.00164	CcSEcCtD
Primidone—Skin disorder—Methotrexate—systemic scleroderma	0.00051	0.00162	CcSEcCtD
Primidone—Anorexia—Methotrexate—systemic scleroderma	0.0005	0.00159	CcSEcCtD
Primidone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000478	0.00152	CcSEcCtD
Primidone—Somnolence—Methotrexate—systemic scleroderma	0.000467	0.00148	CcSEcCtD
Primidone—Decreased appetite—Methotrexate—systemic scleroderma	0.000456	0.00145	CcSEcCtD
Primidone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000453	0.00144	CcSEcCtD
Primidone—Fatigue—Methotrexate—systemic scleroderma	0.000452	0.00144	CcSEcCtD
Primidone—Asthenia—Prednisone—systemic scleroderma	0.000451	0.00143	CcSEcCtD
Primidone—Dizziness—Prednisone—systemic scleroderma	0.000415	0.00132	CcSEcCtD
Primidone—Vomiting—Prednisone—systemic scleroderma	0.000399	0.00127	CcSEcCtD
Primidone—Rash—Prednisone—systemic scleroderma	0.000396	0.00126	CcSEcCtD
Primidone—Dermatitis—Prednisone—systemic scleroderma	0.000396	0.00126	CcSEcCtD
Primidone—Headache—Prednisone—systemic scleroderma	0.000393	0.00125	CcSEcCtD
Primidone—Asthenia—Methotrexate—systemic scleroderma	0.000377	0.0012	CcSEcCtD
Primidone—Nausea—Prednisone—systemic scleroderma	0.000373	0.00119	CcSEcCtD
Primidone—Dizziness—Methotrexate—systemic scleroderma	0.000347	0.0011	CcSEcCtD
Primidone—Vomiting—Methotrexate—systemic scleroderma	0.000334	0.00106	CcSEcCtD
Primidone—Rash—Methotrexate—systemic scleroderma	0.000331	0.00105	CcSEcCtD
Primidone—Dermatitis—Methotrexate—systemic scleroderma	0.000331	0.00105	CcSEcCtD
Primidone—Headache—Methotrexate—systemic scleroderma	0.000329	0.00104	CcSEcCtD
Primidone—Nausea—Methotrexate—systemic scleroderma	0.000312	0.000991	CcSEcCtD
